379 related articles for article (PubMed ID: 9418339)
1. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
Sakran W; Raz R; Colodner R; Keness Y
Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
Sakran W; Raz R; Chazan B; Koren A; Colodner R
Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
Prado V; Romero J; Herrera N; Marinkovic K; Bustos R
Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
[TBL] [Abstract][Full Text] [Related]
4. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
7. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
[TBL] [Abstract][Full Text] [Related]
9. [Sensitivity of group A beta-hemolytic Streptococcus isolated from pediatric pharyngotonsillitis to erythromycin and clarithromycin: a primary care multicenter study].
García de Lomas J; Gimeno C; Díez J; Bermejo M; Navarro D; García-Ponte L
Enferm Infecc Microbiol Clin; 1999 Jan; 17(1):24-8. PubMed ID: 10069109
[TBL] [Abstract][Full Text] [Related]
10. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin resistance in Streptococcus pyogenes in Italy.
Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
[TBL] [Abstract][Full Text] [Related]
12. Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin.
Urbánek K; Kolár M; Cekanová L
Pharm World Sci; 2005 Apr; 27(2):104-7. PubMed ID: 15999920
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
14. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
15. Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India.
Capoor MR; Nair D; Deb M; Batra K; Aggarwal P
Jpn J Infect Dis; 2006 Oct; 59(5):334-6. PubMed ID: 17060703
[TBL] [Abstract][Full Text] [Related]
16. [Emergence of resistance to macrolides in Streptococcus pyogenes].
Vinagre C; Cifuentes M; Valdivieso F; Ojeda A; Prado V
Rev Med Chil; 1999 Dec; 127(12):1447-52. PubMed ID: 10835751
[TBL] [Abstract][Full Text] [Related]
17. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Senses Z; Baysallar M; Gür D; Doğanci L
Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
[TBL] [Abstract][Full Text] [Related]
18. Increasing erythromycin resistance among group A streptococci causing tonsillitis in a tertiary care hospital in southern India.
Brahmadathan KN; Anitha P; Gladstone P
Clin Microbiol Infect; 2005 Apr; 11(4):335-7. PubMed ID: 15760434
[TBL] [Abstract][Full Text] [Related]
19. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
Bergman M; Huikko S; Pihlajamäki M; Laippala P; Palva E; Huovinen P; Seppälä H;
Clin Infect Dis; 2004 May; 38(9):1251-6. PubMed ID: 15127336
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Group A Streptococcus to Antimicrobial Agents in Northern Israel: A Surveillance Study.
Chazan B; Raz R; Edelstein H; Kennes Y; Gal V; Colodner R
Microb Drug Resist; 2015 Oct; 21(5):551-5. PubMed ID: 26430943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
